查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1990185

消化系統醫療設備市場：依產品類型、技術、應用和最終用戶分類－2026-2032年全球市場預測

Gastrointestinal Devices Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，胃腸道醫療設備市場價值將達到 87.6 億美元，到 2026 年將成長至 93.9 億美元，到 2032 年將達到 149.1 億美元，複合年成長率為 7.89%。

主要市場統計數據
基準年 2025 87.6億美元
預計年份：2026年 93.9億美元
預測年份 2032 149.1億美元
複合年成長率 (%) 7.89%

簡要介紹影響胃腸醫療設備創新未來的臨床因素、技術加速發展和相關人員優先事項。

胃腸醫療設備市場正處於臨床需求、快速技術進步和不斷演變的醫療服務模式的交匯點。近年來，診斷影像、治療性內視鏡和止血技術取得了全面進展，這些進展共同促成了更快的臨床決策和更少的侵入性手術。這些趨勢的促進因素包括：對微創手術日益成長的需求、對門診和以護理為基礎的治療方式的日益重視，以及對高解析度成像以識別細微粘膜病變的需求。因此，器械開發人員和臨床團隊正在嘗試使用整合平台，這些平台結合了卓越的光學性能、精密的輔助器具和軟體驅動的工作流程，以縮短手術時間並提高治療精度。

對重塑競爭動態的變革性臨床、技術和商業性變化進行詳細分析，包括手術施行地點、醫療設備的採用以及其他因素。

胃腸醫療設備市場正經歷著變革性的轉變，這些變革正在改變臨床路徑和經營模式。在技​​術層面，高解析度成像和微型化平台使得病變早期檢測成為可能，從而影響診斷演算法和治療策略。同時，光學、機器人和軟體分析的融合催生了新型混合平台，這些平台兼具診斷清晰度和精準干預能力，手術數量也正從住院患者轉向門診和日間手術患者。

全面檢驗2025 年美國關稅將如何改變整個消化器官系統醫療設備製造商的供應鏈、籌資策略和產業計畫。

美國2025年實施的關稅政策對全球消化器官系統醫療設備製造商的供應鏈帶來了許多不利影響，從多方面衝擊了零件採購、生產策略和定價方式。與嚴重依賴進口零件和成品的製造商相比，擁有垂直整合供應鏈和國內生產能力的製造商受到的影響相對較小。因此，採購團隊必須重新評估供應商多元化和近岸外包的機會，以降低關稅帶來的風險。

全面的細分洞察，解釋了產品類型、臨床應用、最終用戶和技術選擇如何驅動差異化的採用和定位。

細分市場分析表明，產品多樣性和功能專業化是整個胃腸病學領域商業化策略和臨床導入路徑的核心。依產品類型分析，主要器械類別包括膠囊內視鏡系統、內視鏡成像系統、內視鏡治療器械和止血器械。在內視鏡成像領域，高解析度內視鏡、超細內視鏡和影像內視鏡等細分子類別針對不同的應用場景，特別是改善黏膜可視化、進入解剖結構狹窄的管腔以及整合數位化工作流程。內視鏡治療器械也呈現類似的分類，包括用於結構性介入的充氣球囊、用於切除病變的息肉切除器械以及用於維持管腔通暢的支架。這些器械的選擇通常取決於病灶的特徵和手術目標。止血裝置進一步細分為止血夾、止血粉和熱凝固裝置，每種裝置的選擇都基於出血原因、可近性和臨床醫生的偏好。

戰略區域洞察，詳細說明美洲、歐洲、中東和非洲以及亞太地區的差異如何影響設備採用、證據需求和商業性方法。

區域趨勢對消化器官系統醫療設備的臨床特性優先順序、報銷槓桿和市場進入策略有顯著影響。在美洲，醫療服務模式的趨勢包括向門診治療的轉變、醫療系統的整合，以及對既能提高處理能力又能維持強力臨床證據的醫療設備日益成長的需求。雖然能夠簡化流程並與集中採購機制相契合的技術在該地區往往迅速普及，但對可靠的上市後數據和可互操作系統的需求仍然存在。

關鍵企業策略和競爭行動揭示了平台領導者、敏捷創新者和製造合作夥伴如何塑造市場軌跡。

消化器官系統醫療設備產業的競爭格局由成熟的平台供應商、目標明確的創新者和垂直整合的製造商組成。主要企業通常會投資於全面的臨床試驗項目、嚴格的上市後監測以及與醫療系統的合作，以證明其產品的價值。這些企業通常利用模組化平台實現分階段升級，有助於從長期部署基地以及耗材和配件的持續收入中獲利。

為製造商和供應商提供切實可行的優先建議，以加快採用速度、增強韌性，並在臨床環境中實現商業性差異化。

產業領導企業應優先考慮一系列切實可行的舉措，以在整個胃腸醫療設備市場實現臨床、營運和商業性價值。首先，產品開發必須與可衡量的臨床結果和工作流程效率保持一致，以便採購委員會能夠輕鬆量化其價值。投資產生真實世界數據 (REW)，以證明手術時間縮短、併發症率降低或診斷準確性提高，將加速保險公司和醫療機構對產品的接受度。其次，供應鏈應實現多元化，並開發模組化設計，以便在不影響臨床療效的前提下進行組件替換。這有助於降低政策引發的成本衝擊，並支持靈活的生產能力。

對基於三角測量的調查方法進行透明的解釋，該方法結合了主要臨床發現、二手文獻檢驗和基於情境的供應鏈分析。

本執行摘要的研究整合採用了三角測量法，結合了與主要相關人員的對話、二手證據的整合以及基於情境的供應鏈分析。主要資訊來源包括對臨床意見領袖、採購經理和產品開發經理的結構化訪談，以了解他們對產品可用性、臨床優先事項和商業性限制的實際觀點。二級資訊來源利用了同行評審的臨床文獻、監管指導文件和已發布的最佳實踐，以檢驗有關臨床表現的論斷，並確保其符合當前的護理標準。

簡潔結論總結了技術創新、價值鏈韌性和證據生成如何決定永續採用和價值創造。

總之，胃腸醫療設備產業的特點是技術快速進步、醫療服務模式轉移，以及日益複雜的商業環境，後者強調主導創新和營運韌性。高清影像、機器人技術和新型止血技術正在重新定義診斷和治療的可能性，而門診服務的擴展和區域差異則要求制定量身定做的商業策略。 2025年的定價凸顯了供應鏈柔軟性和成本建模的戰略重要性，不僅要考慮組件成本，還要考慮總落地成本。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：胃腸道醫療設備市場：依產品類型分類

  • 膠囊內視鏡系統
  • 內視鏡成像系統
    • 高解析度內視鏡
    • 超細內視鏡
    • 影像內視鏡
  • 內視鏡治療設備
    • 膨脹的氣球
    • 息肉切除裝置
    • 支架
  • 止血裝置
    • 夾子
    • 止血粉
    • 熱固化裝置

第9章：胃腸道醫療設備市場：依技術分類

  • 膠囊內視鏡
  • 光學內視鏡
    • 軟式內視鏡
    • 硬式內視鏡
  • 機器人輔助內視鏡
  • 超音波超音波
    • 線性超音波內視鏡
    • 超音波

第10章：胃腸道醫療設備市場：依應用領域分類

  • 出血控制
    • 機械止血
    • 噴霧型止血劑
    • 熱凝固
  • 診斷影像
    • 病灶可視化
    • 運動功能評估
  • 息肉檢測
  • 狹窄區域的擴張

第11章：胃腸道醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 診斷中心
  • 醫院
  • 專科診所

第12章：胃腸道醫療設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：胃腸道醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：胃腸道醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國胃腸道醫療設備市場

第16章：中國胃腸醫療設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Asahi Kasei Medical Co., Ltd.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Group Incorporated
  • Fujifilm Holdings Corporation
  • Getinge AB
  • Johnson & Johnson Services, Inc.
  • Karl Storz SE & Co. KG
  • Leo Medical Co.,Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Micro-Tech（Nanjing）Co., Ltd.
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • Pentax Medical by HOYA Corporation
  • Prion Medical BV
  • Richard Wolf GmbH
  • Siemens Healthineers AG
  • Smith+Nephew
  • STERIS Corporation
  • Stryker Corporation
  • Teleflex Incorporated
  • WL Gore & Associates, Inc.
Product Code: MRR-7949F05839D3

The Gastrointestinal Devices Market was valued at USD 8.76 billion in 2025 and is projected to grow to USD 9.39 billion in 2026, with a CAGR of 7.89%, reaching USD 14.91 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.76 billion
Estimated Year [2026] USD 9.39 billion
Forecast Year [2032] USD 14.91 billion
CAGR (%) 7.89%

Concise introduction framing clinical drivers, technological acceleration, and stakeholder priorities shaping the future of gastrointestinal device innovation

The gastrointestinal devices landscape sits at the confluence of clinical necessity, technological acceleration, and evolving care delivery models. Recent years have seen end-to-end advances in diagnostic imaging, therapeutic endoscopy, and hemostasis that together shift clinical decision making earlier and reduce invasive interventions. These trends are driven by rising demand for minimally invasive procedures, a growing emphasis on outpatient and ambulatory care, and the necessity for higher-resolution visualization to identify subtle mucosal lesions. In turn, device developers and clinical teams are experimenting with integrated platforms that couple superior optics, refined accessory tools, and software-enabled workflows to shorten procedure time and enhance therapeutic precision.

Against this backdrop, stakeholders from hospital systems to specialty clinics are prioritizing devices that demonstrably improve throughput, lower complications, and enable remote or hybrid care pathways. Policymakers and payers are also influencing adoption through updated reimbursement frameworks that favor value-based outcomes. Moreover, device manufacturers face an increasingly complex regulatory environment in which evidence generation and post-market surveillance carry heightened importance. Taken together, these dynamics set the stage for a highly competitive innovation cycle, where clinical efficacy, workflow compatibility, and economic value determine which technologies achieve scale and which remain niche solutions.

In-depth analysis of the transformative clinical, technological, and commercial shifts reshaping procedure locations, device adoption, and competitive dynamics

The gastrointestinal device landscape is undergoing transformative shifts that are altering clinical pathways and commercial models. Technologically, higher-definition imaging and miniaturized platforms are enabling lesion detection at earlier stages, thereby influencing diagnostic algorithms and therapeutic intent. Concurrently, the convergence of optics, robotics, and software analytics is producing new hybrid platforms that couple diagnostic clarity with precise intervention capabilities, shifting procedural volumes from inpatient to ambulatory settings.

Operationally, the migration toward outpatient and ambulatory surgical centers is reshaping purchasing priorities; providers prioritize disposables that reduce turnover time and capital equipment that delivers robust utilization metrics. Meanwhile, digital integration, including enhanced image management and procedural analytics, is enabling performance benchmarking and remote proctoring, which accelerate clinician adoption curves. Regulatory and reimbursement practice updates are further incentivizing devices that show clear outcomes and cost-efficiencies. In market terms, smaller fast-moving innovators are challenging incumbent suppliers by targeting unmet clinical niches with focused, evidence-backed solutions. As a result, the competitive landscape favors agility, clinical trial rigor, and scalable manufacturing strategies that can support rapid market entry and iterative device improvements.

Comprehensive examination of how the 2025 U.S. tariffs reshaped supply chains, sourcing strategies, and commercial planning across gastrointestinal device makers

The tariff environment introduced by the United States in 2025 has created headwinds across global supply chains for gastrointestinal device manufacturers, with layered effects on component sourcing, manufacturing strategies, and pricing approaches. Manufacturers with vertically integrated supply chains or domestic production capacity experienced relative insulation compared with those that rely heavily on imported subassemblies or finished devices. As a consequence, procurement teams have had to reassess supplier diversity and nearshoring opportunities to mitigate exposure to applied duties.

In practice, the cumulative tariff impact extended beyond direct cost increases, influencing contractual negotiations and lead-time planning. OEMs and contract manufacturers began to restructure agreements to shift risk or incorporate tariff clauses, while strategic buyers accelerated dual-sourcing strategies to preserve continuity. Furthermore, some firms responded by qualifying alternative suppliers from tariff-favored regions or by investing in modular design changes that allowed substitution of affected components without compromising clinical performance. Importantly, this period strengthened the business case for greater supply chain transparency and scenario planning, with commercial teams increasingly modeling total landed cost rather than unit price alone. Taken together, the tariff developments underscored the necessity for resilience-oriented procurement, flexible manufacturing footprints, and commercial strategies that anticipate policy volatility without undermining clinical adoption timelines.

Holistic segmentation insights explaining how product categories, clinical applications, end users, and technology choices drive differentiated adoption and positioning

Segmentation insight reveals that product diversity and functional specialization are central to commercialization strategies and clinical adoption pathways across the gastrointestinal space. When analyzed by product type, key device categories include capsule endoscopy systems, endoscopic imaging systems, endotherapy devices, and hemostasis devices. Within endoscopic imaging, the differentiated subcategories of high-definition endoscopes, ultrathin endoscopes, and video endoscopes each address distinct clinical use cases: enhanced mucosal visualization, access to anatomically narrow lumens, and integrated digital workflows respectively. Endotherapy devices display similar stratification, where dilation balloons serve structural interventions, polypectomy devices address lesion resection, and stents support luminal patency; the choice among these tools often depends on lesion characteristics and procedural intent. Hemostasis devices further stratify into clips, hemostatic powders, and thermal coagulation devices, each selected based on bleeding etiology, accessibility, and clinician preference.

From an application standpoint, devices are deployed across bleeding management, diagnostic imaging, polyp detection, and stricture dilation. Bleeding management itself breaks down into mechanical hemostasis, sprayable hemostats, and thermal coagulation modalities, with selection influenced by bleed source and procedural context. Diagnostic imaging applications include lesion visualization and motility assessment, reflecting a dual focus on structural and functional diagnostics. In terms of end users, the buyer landscape spans ambulatory surgical centers, diagnostic centers, hospitals, and specialty clinics, each with different purchasing cycles, capital constraints, and utilization expectations. Finally, the technology axis differentiates capsule endoscopy, optical endoscopy, robotic endoscopy, and ultrasound endoscopy. Optical systems further bifurcate into flexible and rigid endoscopes, while ultrasound endoscopy differentiates into linear and radial ultrasound endoscopes, reflecting divergent imaging geometries and clinical indications. Integrating these segmentation perspectives clarifies how product development, commercial positioning, and evidence generation must align to meet the heterogeneous needs of clinicians and care settings.

Strategic regional insights detailing how Americas, Europe, Middle East & Africa, and Asia-Pacific differences shape device adoption, evidence needs, and commercial approaches

Regional dynamics materially influence prioritization of clinical features, reimbursement levers, and go-to-market strategies for gastrointestinal devices. In the Americas, healthcare delivery trends emphasize outpatient shift, consolidation of health systems, and an appetite for devices that improve throughput while maintaining strong clinical evidence. This region commonly demonstrates rapid uptake of technologies that align with procedural efficiency and centralized purchasing mechanisms, but also expects robust post-market data and interoperable systems.

In Europe, Middle East & Africa, heterogeneity in regulatory frameworks and reimbursement pathways means market entry strategies must be highly localized. Western European markets often demand rigorous clinical validation and demonstrate steady adoption for high-definition imaging and integrated platforms, whereas some emerging markets in the region prioritize cost-effective disposables and modular solutions. In the Middle East and Africa, infrastructure constraints and import logistics drive preference for durable equipment, simplified maintenance, and flexible training support. Across Asia-Pacific, diverse healthcare delivery models range from highly advanced tertiary care centers that adopt leading-edge endoscopic robotics to rapidly growing ambulatory networks in urban centers seeking commercially viable, scalable devices. Procurement strategies here frequently balance accelerated adoption in metropolitan hubs against price sensitivity in broader geographies. Recognizing these regional distinctions enables manufacturers to tailor clinical evidence packages, service models, and commercial approaches in ways that respect local decision drivers and accelerate sustainable adoption.

Key corporate strategies and competitive behaviors revealing how platform leaders, agile innovators, and manufacturing partners shape market trajectories

Competitive dynamics in the gastrointestinal devices arena are defined by a mix of established platform providers, targeted innovators, and vertically integrated manufacturers. Leading firms typically invest in comprehensive clinical programs, rigorous post-market surveillance, and partnerships with healthcare systems to demonstrate value. These companies often leverage modular platforms that allow incremental upgrades, facilitating long-term installed-base monetization and recurring revenue from consumables and accessories.

At the same time, smaller specialist firms and start-ups drive innovation in narrow clinical niches by rapidly iterating on design and leveraging focused clinical trials to capture early adopters. Their agility enables experimentation with alternative business models, such as service-based offerings or bundled procedural pricing, which can accelerate penetration in ambulatory and diagnostic center settings. Contract manufacturing organizations and component specialists have also become strategic partners; they enable cost-effective scaling and help OEMs navigate tariff-induced supply chain shifts by offering distributed manufacturing footprints. Across this ecosystem, companies that align rigorous clinical evidence with clear economic arguments and strong training and service models tend to outperform peers. Strategic alliances, co-development arrangements, and targeted acquisitions remain common approaches to augment technology portfolios and accelerate access to complementary channels and geographies.

Practical and prioritized recommendations for manufacturers and providers to enhance adoption, resilience, and commercial differentiation across clinical settings

Industry leaders should prioritize a set of pragmatic actions to capture clinical, operational, and commercial value across the gastrointestinal device landscape. First, align product development with measurable clinical outcomes and workflow efficiency gains so that procurement committees can readily quantify value. Investing in real-world evidence generation that demonstrates reduced procedure time, lower complication rates, or improved diagnostic yields will accelerate payer and institutional acceptance. Second, diversify supply chains and develop modular designs that allow component substitution without clinical compromise; this will reduce exposure to policy-driven cost shocks and support flexible manufacturing.

Third, tailor go-to-market approaches by end-user segment and region, recognizing that hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics have different capital cycles and utilization expectations. Fourth, build robust training and service programs that reduce learning curves and ensure consistent clinical outcomes; remote proctoring and digital training modules can be cost-effective ways to scale education globally. Fifth, explore innovative commercial models such as outcome-linked pricing, refurbished equipment programs, and consumable subscription models to align incentives with volume and value. Finally, pursue targeted partnerships to complement internal capabilities-whether for imaging software, robotics, or advanced materials-so that product roadmaps can accelerate while mitigating integration risk. Collectively, these actions can improve adoption velocity and create defensible value propositions in a competitive marketplace.

Transparent description of the triangulated research methodology combining primary clinical insights, secondary literature validation, and scenario-based supply chain analysis

The research synthesis underpinning this executive summary employed a triangulated methodology that combined primary stakeholder engagements with secondary evidence synthesis and scenario-based supply chain analysis. Primary inputs included structured interviews with clinical opinion leaders, procurement executives, and product development leaders to capture frontline perspectives on usability, clinical priorities, and commercial constraints. Secondary sources comprised peer-reviewed clinical literature, regulatory guidance documents, and published procedural best practices to validate clinical performance claims and to ensure alignment with current standards of care.

To understand operational resilience, scenario modeling was conducted to evaluate supply chain disruption vectors and tariff impacts, assessing mitigation options such as supplier diversification and nearshoring. Data validation steps included cross-referencing clinician-reported preferences with device utilization trends and post-market safety bulletins. The methodological approach prioritized transparency in assumptions, documented data provenance, and iterative validation with domain experts to minimize bias. Where evidence gaps were identified, recommended data collection pathways are included to support future iterations of the analysis, such as focused clinical registries or payer claims modeling to better quantify downstream economic outcomes.

Concise conclusion summarizing how technological innovation, supply chain resilience, and evidence generation determine sustainable adoption and value creation

In conclusion, the gastrointestinal devices domain is characterized by rapid technological progress, shifting care delivery paradigms, and an increasingly complex commercial environment that rewards evidence-driven innovation and operational resilience. High-definition imaging, robotics, and novel hemostasis modalities are redefining diagnostic and therapeutic possibilities, while outpatient care growth and regional variations necessitate tailored commercial strategies. The 2025 tariffs highlighted the strategic importance of supply chain flexibility and cost modeling that account for total landed cost rather than component price alone.

Looking ahead, organizations that pair rigorous clinical validation with adaptable manufacturing and pragmatic go-to-market models will be best positioned to scale. Equally important is the ability to provide comprehensive training and service to ensure consistent outcomes across diverse clinical settings. Ultimately, success will hinge on aligning product performance with measurable clinical benefit and economic value, enabling stakeholders to adopt innovations that improve patient care while sustaining long-term commercial viability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Devices Market, by Product Type

  • 8.1. Capsule Endoscopy Systems
  • 8.2. Endoscopic Imaging Systems
    • 8.2.1. High Definition Endoscopes
    • 8.2.2. Ultrathin Endoscopes
    • 8.2.3. Video Endoscopes
  • 8.3. Endotherapy Devices
    • 8.3.1. Dilation Balloons
    • 8.3.2. Polypectomy Devices
    • 8.3.3. Stents
  • 8.4. Hemostasis Devices
    • 8.4.1. Clips
    • 8.4.2. Hemostatic Powders
    • 8.4.3. Thermal Coagulation Devices

9. Gastrointestinal Devices Market, by Technology

  • 9.1. Capsule Endoscopy
  • 9.2. Optical Endoscopy
    • 9.2.1. Flexible Endoscopes
    • 9.2.2. Rigid Endoscopes
  • 9.3. Robotic Endoscopy
  • 9.4. Ultrasound Endoscopy
    • 9.4.1. Linear Ultrasound Endoscopes
    • 9.4.2. Radial Ultrasound Endoscopes

10. Gastrointestinal Devices Market, by Application

  • 10.1. Bleeding Management
    • 10.1.1. Mechanical Hemostasis
    • 10.1.2. Sprayable Hemostats
    • 10.1.3. Thermal Coagulation
  • 10.2. Diagnostic Imaging
    • 10.2.1. Lesion Visualization
    • 10.2.2. Motility Assessment
  • 10.3. Polyp Detection
  • 10.4. Stricture Dilation

11. Gastrointestinal Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Specialty Clinics

12. Gastrointestinal Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Gastrointestinal Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Gastrointestinal Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Gastrointestinal Devices Market

16. China Gastrointestinal Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Asahi Kasei Medical Co., Ltd.
  • 17.7. Becton, Dickinson and Company
  • 17.8. Boston Scientific Corporation
  • 17.9. CONMED Corporation
  • 17.10. Cook Group Incorporated
  • 17.11. Fujifilm Holdings Corporation
  • 17.12. Getinge AB
  • 17.13. Johnson & Johnson Services, Inc.
  • 17.14. Karl Storz SE & Co. KG
  • 17.15. Leo Medical Co.,Ltd.
  • 17.16. Medtronic plc
  • 17.17. Merit Medical Systems, Inc.
  • 17.18. Micro-Tech (Nanjing) Co., Ltd.
  • 17.19. Olympus Corporation
  • 17.20. Ovesco Endoscopy AG
  • 17.21. Pentax Medical by HOYA Corporation
  • 17.22. Prion Medical BV
  • 17.23. Richard Wolf GmbH
  • 17.24. Siemens Healthineers AG
  • 17.25. Smith+Nephew
  • 17.26. STERIS Corporation
  • 17.27. Stryker Corporation
  • 17.28. Teleflex Incorporated
  • 17.29. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROINTESTINAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 228. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 229. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 232. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 233. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 235. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 236. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 264. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 265. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 266. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 268. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 269. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 271. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 272. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 276. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 277. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 278. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 279. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 280. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 281. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 283. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 284. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLI